Skip to content

H.R. 6485 · 119th Congress (2025–2027)

Skinny Labels, Big Savings Act

This bill provides a statutory safe harbor from patent infringement claims for generic or biosimilar manufacturers that seek or obtain approval for skinny labels of their drugs.

Under current law, the Food and Drug Administration (FDA) may approve generic and biosimilar drugs through a process known as skinny labeling, which allows a generic manufacturer to seek approval only for approved uses of the drug that are no longer protected by patents. However, in GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., a court held that a generic manufacturer may sometimes be liable for patent infringement when it markets skinny label generics.

The bill specifically lists the following as actions that are not considered infringement of a method of use claim in a patent under the Federal Food, Drug, and Cosmetic Act:

  • submitting or seeking approval of a skinny label for a generic or biosimilar drug;
  • promoting or commercially marketing a drug with skinny labeling approved by the FDA; or
  • describing a drug product approved by the FDA as a generic of, or therapeutically equivalent to, the branded drug.

The bill also applies the safe harbor to similar actions under the Public Health Service Act.

Show official title

To amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 6485’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Ben Cline (R-VA-6)
Cosponsors
6 cosponsors

1 original · 5 later

3 R · 3 D

  1. Rep. Zoe Lofgren (D-CA-18)· Original · Dec 5, 2025
  2. Rep. Jennifer A. Kiggans (R-VA-2)· Later · Apr 20, 2026
  3. Rep. Thomas R. Suozzi (D-NY-3)· Later · Apr 20, 2026
  4. Rep. August Pfluger (R-TX-11)· Later · May 19, 2026
  5. Rep. Glenn Grothman (R-WI-6)· Later · Jun 15, 2026
  6. Rep. Angie Craig (D-MN-2)· Later · Jun 23, 2026
Policy area
Commerce

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on the Judiciary.

    Sources

Committees

  1. HouseJudiciaryReferred Dec 5, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Skinny Labels, Big Savings Act

    Display title, Short title · Introduced in House

  2. To amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.

    Official title · Introduced in House